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The swelling-activated chloride current (ICl,swell) is induced when a cell swells and 
plays a central role in maintaining cell volume in response to osmotic stress. The 
major contributor of ICl,swell is the volume regulated anion channel (VRAC). LRRC8A 
(SWELL1) was recently identified as an essential component of VRAC but the 
mechanisms of VRAC activation are still largely unknown; moreover, other Cl- 
channels, such as anoctamin 1 (ANO1) were also suggested to contribute to ICl,swell. In 
this present study, we investigated the roles of LRRC8A and ANO1 in activation of 
ICl,swell; we also explored the role of intracellular Caβ+ in ICl,swell activation. We used 
CRISPR/Cas9 gene editing approach, electrophysiology, live fluorescent imaging, 
selective pharmacology and other approaches to show that both LRRC8A and ANO1 
can be activated by cell swelling in HEKβ9γ cells. Yet, both channels contribute 
biophysically and pharmacologically distinct components to ICl,swell, with LRRC8A 
being the major component. Cell swelling induced oscillatory Caβ+ transients and 
these Caβ+ signals were required to activate both, the LRRC8A- and ANO1-dependent 
components of ICl,swell. Both ICl,swell components required localized rather than global 
Caβ+ for activation. Interestingly, while intracellular Caβ+ was necessary and sufficient 
to activate ANO1, it was necessary but not sufficient to activate LRRC8A-mediated 
currents. Finally, Caβ+ transients linked to the ICl,swell activation were mediated by the 
GPCR-independent PLC isoforms.  
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Volume regulated anion channel (VRAC) is widely expressed in most cell types; it 
mediates swelling activated Cl- currents (ICl,swell), which are necessary for cell volume 
regulation. Being permeable to a range of  organic and inorganic anions, VRAC 
plays many other important roles in cells, including proliferation, release of excitatory 
amino acids, apoptosis and germ cell development (β1, γ9, 45, 48). It is also 
suggested that VRAC is involved in a variety of human diseases, including stroke, 
diabetes and cancer (46, 5β, 59). The molecular identity of VRAC remained unknown 
until recently, when the family of leucine-rich repeat containing 8 (LRRC8) proteins 
(also known as Swell) was identified as crucial components of VRAC (47, 57). 
LRRC8 family contains five members (LRRC8A-E), all of which share a high degree 
of sequence similarity (1β). Whereas LRRC8A is the only obligatory subunit of 
VRAC, it still needs at least one of the other LRRC8 isoforms (57) to form a 
functional channel. The LRRC8 subunit composition determines not only biophysical 
properties of VRAC, such as inactivation kinetics and single channel conductance, but 
more importantly its substrate specificity (γ1, 46, 5γ, 55). Recently, the structures of 
LRRC8 family were determined by cryo-electron microscope and X-ray 
crystallography (1β, β4). These reports revealed that VRAC is a hexameric protein 
with a modular structure. 
However, it has to be noted that many other Cl- channels and transporters may also 
contribute to cell volume regulation. Notably, Caβ+-activated chloride channels ANO1, 
ANO6 and bestrophin were all reported to be involved in osmotic regulation (4, 6, 15, 
β5, γ4, 44). 
ANO1 (anoctamin-1), also known as TMEM16A, is the Ca2+ ctivated chloride 
channel (CaCC) of the anoctamin family (ANO1-10) (8, 50, 58). Recent studies 
indicate that three anoctamin family members (ANO1, 6, and 10) may be involved in 
cell volume regulation (4, 18, 42). Thus, freshly isolated tissues from the ANO1, 
ANO6, or ANO10 knock-out mice show reduced regulatory volume decrease (RVD) 
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(4, 18, 42). It is, however, not clear whether these anoctamin proteins affect cell 
volume directly by acting as Cl- channels, or indirectly by contributing to Ca2+ 
signaling (23, 49). In addition, another CaC, bestrophin1, was also shown to be 
crucial for regulation of cell volume in mouse sperm and human retinal pigment 
epithelium cells (34). 
The mechanism of ICl,swell activation has long been debated; it is also not entirely clear 
whether the LRRC8-mediated VRAC is the sole contributor of ICl,swell (2, 20, 41). 
Many cellular signaling cascades have been suggested to participate in the VRAC 
activation mechanism and among these the contribution of intracellular Ca2+ signaling 
has been discussed frequently because cell swelling usually is accompanied by rises in 
the intracellular Ca2+ concentration ([Ca2+] i) in many cell types (1-3, 37). It was also 
suggested that local Ca2+ signals are probably also required for activation of VRAC 
(5). Yet, the exact role of Ca2+ in activation of VRAC is not clear.  
As mentioned, ANO1 channels were also reported to contribute to ICl,swell (4); 
moreover, it was ported that ANO1 is activated by an increase in compartmentalized 
Ca2+ (βγ, β6), hence, we set out to investigate roles of LRRC8A and ANO1 in ICl,swell 
activation and test the potential role of Ca2+ in activation of LRRC8A- and 
ANO1-mediated components of ICl,swell. We also tested if source of intracellular Ca2+ 
matters for the activation of VRAC or ICl,swell. In this work we use the following terms 
to define closely related but distinct phenomena: i) term ICl,swell is used to denote 
swelling-activated Cl- current, independent of its molecular identity; ii) term VRAC is 
used to denote volume regulated anion channel mediated by LRRC8 proteins; iii) term 
CaCC is used to denote Ca2+- ctivated Cl- channels.  
 
Materials and methods 
Cell culture 
HEK293/CHO cells were cultured in DMEM/F12K with 10% fetal bovine serum 
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(FBS) and 1% penicillin/streptomycin at 37°C in a humidified atmosphere of air with 
5% CO2. The ANO1 stably transfected HEK293 cells were established in our 
laboratory (30) and were cultured in DMEM supplemented with 10% FBS, 600 たg/ml 
G418 and 1% penicillin/streptomycin. DRG neurons were extracted from all spinal 
levels of 21-day-old Wistar rats, and neurons were dissociated and cultured as 
described (28). No growth factors were added to the culture medium (DMEM 
supplemented with GlutaMAX I (Invitrogen), 10% FBS and 1% 
penicillin/streptomycin). For the patch-clamp analysis cells were removed from the 
culture flask by a 1-min digestion with 2.5 mg/ml trypsin (1:250) and plated at low 
density onto 12-mm-diameter glass coverslips in 24-well tissue culture plates. The 
cells were used for recording within 48 h after plating. 
cDNA and Transfection 
The mouse ANO1 cDNA clone was kindly provided by Prof. Uhtaek Oh (Seoul 
National University, Korea) and was subcloned to expression vector pEGFPN1. The 
human LRRC8A cDNA clone was kindly provided by Prof. Thomas J. Jentsch 
(Neurocure, Charité Universitätsmedizin, Berlin, Germany). The LRRC8A knockout 
HEK293 (LRRC8A-/-)cells were transfected with above channel DNA constructs for 
4-6 h with Lipofectamine 2000 (Invitrogen, USA) according to the manufacturer’s 
instructions. The cells were used for patch-clamp recording 24 h after transfection. 
CRISPR/Cas9 approach 
The ANO1 and LRRC8A knockout HEK293 cells were established using 
CRISPR/Cas9 approach (Beijing Biocytogen Co., Ltd., Beijing, China) and were 
cultured in DMEM with 10% FBS and 1% penicillin/streptomycin. To generate the 
knockout cell lines, pCS-sgRNA plasmids and targeting vector were co-electroporated 
into HEK293 cell line. After Electroporation, cells were treated with 1 たg/mL 
puromycin for 10 days. And then, resistant clones were picked and expanded for 
genotyping. 
For detection of positive ANO1 and LRRC8A knockout HEK293 cell line clones, the 
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The primers ANO1-GT-F/PGK-GT-R, ANO1-MSD-F/ANO1-MSD-R; 
LRRC8A-GT-F/PGK-GT-R and LRRC8A-MSD-F/LRRC8A-MSD-R were 
respectively used to detect HR and non-HR allele. 
Electrophysiology  
Currents were recorded using a MultiClamp 700B amplifier and pCLAMP 10.0 
software (Molecular Devices, Sunnyvale, CA) and were filtered at 2 kHz. Patch 
electrodes with resistances of 2-5Mっ were pulled with a horizontal micropipette 
puller (P-97, Sutter Instruments, USA) and fire polished. The intracellular recording 
pipette solutions include: (1) the high Ca2+ pipette solution (in mM)(30): 130 CsCl, 10 
EGTA, 1 MgCl2, 10 HEPES, 2 Mg-ATP, 8 CaCl2 (447 nM free Ca2+, calculated with 
the MAXC program, Stanford University, Stanford, CA, USA); pH adjusted to 7.3 
with CsOH. (2) The hypertonic pipette solution (in mM): 140 CsCl, β.4 MgClβ, 0.5 
CaClβ, 5 EGTA, 10 HEPES, 5 Mg-ATP and 0.5 Na-GTP; pH 7.3 adjusted with CsOH; 
osmolality adjusted to 420 mOsm with sucrose. (3) The isosmotic pipette solution (in 
mM): 1γ0 CsCl, β.4 MgClβ, 0.5 CaClβ, 5 EGTA, 10 HEPES, 5 Mg-ATP and 0.5 
Na-GTP; pH 7.3 adjusted with CsOH; osmolality adjusted to 320 mOsm with sucrose. 
The extracellular recording bath solutions include: ķ the isosmotic bath solution (in 
mM): 145 NaCl, 2 CaCl2, 2 MgCl2, 10 Glucose, 10 HEPES; pH 7.4 adjusted with 
NaOH; osmolality adjusted to 320 mOsm with sucrose. ĸ The isosmotic bath 
solution (in mM) : 95 NaCl, 100 mannitol, 0.4 KH2PO4, 1.6 K2HPO4, 6 D-glucose, 1 
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MgCl2, 2 CaCl2; pH 7.4 adjusted with NaOH; osmolality adjusted to 320 mOsm with 
sucrose. Ĺ The hypotonic bath solution (in mM): 95 NaCl, 0.4 KH2PO4, 1.6 
K2HPO4, 6 D-glucose, 1 MgCl2, 2 CaCl2; pH 7.4 adjusted with NaOH; osmolality 
adjusted to 220 mOsm with sucrose (this hypotonic bath solution is paired to the 
isosmotic bath solution ĸ and isosmotic pipette solution (3)). All recording were 
performed at room temperature. 
Intracellular Ca2+ imaging 
HEK293 cells were grown on glass coverslips and cultured for 24 h. For 
Ca2+-sensitive fluorescence detection, cells were loaded with Fluo-4-AM (β たM) in 
the presence of Pluronic F-127 (0.02%) for 45 min at 37°C and the coverslips were 
placed into a flow-through chamber and mounted on an inverted microscope for 
confocal imaging. A Leica SP5 (Nussloch, Germany) DM-IRBE inverted microscope 
with a 20× objective (numerical aperture, 0.7) and a TCS-SP5 scan-head was used. 
The Fluo-4 was excited at 488 nm and the emitted fluorescence signal was detected at 
520 nm. A time-laps series of confocal images were taken at 2 s intervals and were 
stored on a computer hard drive. Laser intensity and pinhole settings were kept 
constant between the experiments. The pinhole diameter was set to scan sections with 
a thickness of 0.28 m. Control images were obtained for 2-5 min before test solution 
application. Hypotonic bath solution was applied for at least 20 min. TCS-SP5 
confocal software (Leica) was used to analyze data off line. 
Chemicals 
NFA, DCPIB, CaCCinh-A01, Thapsigargin, U73122̍ U73343ˈ GDP-くs ˈ
Bisindolylmaleimide1 (BIM) and GTP-S were purchased from Sigma (St Louis, MO, 
USA). These compounds were dissolved in DMSO and were kept at -20°C. Stock 
solutions were diluted to final concentrations in bath solution or intracellular solution. 
The final concentration of DMSO in bath solution or intracellular solution is no more 
than 0.1%. The vehicle at the final concentrations was tested and found having not 
effect on the currents measured. All final drug solutions were freshly made before 
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each experiment and kept away from light. 
Data analysis and statistics 
The summary statistics of current densities were measured at -60 mV or +100 mV 
when the currents reached the maximum (oscillation) or relatively stable (no 
oscillation). Results were expressed as means ± S.E.M. Student’s test (unpaired and 
paired) and one-way ANOVA were used to assess statistical significance. Difference 
between means was considered significant at P<0.05. Concentration-response curves 
were fitted with the logistic equation: y=A2+ (A1-A2)/ (1+(x/x0) p), where y is the 
response; A1 and A2 are the maximum and minimum response, respectively, x is the 
drug concentration, and p is the Hill coefficient. 
 
Results 
Localized intracellular Ca2+ plays an essential role in activation of ICl,swell 
We first examined activation of ICl,swell by cell swelling in HEKβ9γ cells (Fig. 1). An 
outwardly rectifying current gradually developed when the whole-cell currents were 
recorded using a hypertonic (4β0 mOsm) pipette solution in HEKβ9γ cells. This 
current showed fast activation and slow inactivation at the highly positive voltages 
and could be inhibited by Cl- channel blockers DCPIB (10 M) (Fig. 1A) and 
CaCCinh-A01 (100 M, data not shown). In most cases, oscillations of the current 
amplitude were seen (Fig. 1A). 
It has been suggested that intracellular Caβ+ is an important component in activation 
of swelling-induced currents (β0, ββ). To investigate the role of intracellular Caβ+ in 
activation of ICl,swell, we tested the effects of two Caβ+ chelators: Ethylene glycol-bis 
(-aminoethyl ether)-N,N,N’,N’-tetraacetic acid (EGTA) and 1,β-Bis (β-amino-5- 
methylphenoxy) ethane-N,N,N’,N’-tetraacetic acid (BAPTA), as well as thapsigargin, 
a blocker of sarco-endoplasmic reticulum Caβ+-ATPase (SERCA) on the development 
of ICl,swell. BAPTA and EGTA have similar affinity for Caβ+ but have markedly 
different binding kinetics; BAPTA binds Caβ+ nearly 100-fold faster than EGTA (β7, 
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γ5, γ6). These two Caβ+ chelators are thus often used to distinguish between ‘local’ 
and ‘global’ Caβ+ signals as highly localized, micro- or nano- domain Caβ+ signals are 
minimally affected by slow chelator EGTA but usually can be efficiently precipitated 
by BAPTA. In contrast, slower, global Caβ+ signals are well prevented by both EGTA 
and BAPTA (γγ). As shown in Fig. 1B and 1C, addition of β0 mM BAPTA greatly 
reduced the ICl,swell amplitude while β0 mM EGTA had no effect. When cells were 
pre-incubated with thapsigargin (β M; 15 min) and the recording of ICl,swell was 
performed (still in the presence of thapsigargin), the current was also abolished (Fig. 
1B, lower panel and 1C). It is interesting to note that although EGTA did not affect 
the ICl,swell amplitude, the oscillation of ICl,swell was not observed any more in the 
presence of EGTA (Fig. 1B; 0/14 recordings in the presence of β0 mM EGTA 
displayed oscillations vs. β6/β6 recordings in the control condition with 5 mM EGTA). 
This similar effects of EGTA and BAPTA on ICl,swell were also observed in another 
two cell types: CHO cells (CHO-ANO1) and rat dorsal root ganglion neurons (Fig. 
1D and 1E). 
In another series of experiments we used a hypotonic extracellular bath solution (ββ0 
mOsm) instead of a hypertonic pipette solution (4β0 mOsm) to induce cell swelling. 
The hypotonic bath solution induced activation of ICl,swell with similar properties and 
amplitudes as the hypertonic pipette solution (Fig. βA and βE). Sensitivity of ICl,swell 
induced by extracellular hypotonicity to EGTA and BAPTA was similar to that 
observed for ICl,swell induced by hypertonic intracellular solution: β0 mM EGTA in the 
pipette solution had no effect, while β0 mM BAPTA almost completely abolished 
these currents (Fig. βB and βF). In addition, we also investigated the effect of 
extracellular Caβ+ on ICl,swell and the results showed that chelation of extracellular Caβ+ 
had no obvious effect on ICl,swell (Fig. βA, lower panel and βE).  
We next studied if the osmotic cell swelling would indeed induce a rise in intracellular 
Caβ+, as has been reported (β0, ββ). The hypotonic bath solution induced transient 
Caβ+ rises in all the HEKβ9γ cells tested (Fig. βC, shown are the time courses of 
fluorescence intensity changes from randomly selected three cells indicated by white 
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arrows). Similar to the ICl,swell, in most of the cells the Caβ+ transients were oscillating 
(Fig. βC, left panel). To evaluate temporal correlation between the ICl,swell and Caβ+ 
oscillations we calculated and compared the intervals between the first and second 
peaks of ICl,swell and between the maxima of the first two Caβ+ transients. These 
intervals were 9.7 ± 0.9 min (n=18) and 4.7 ± 0.4 min (n=β5), respectively, suggesting 
that the ICl,swell oscillations were significantly slower than Caβ+ oscillation. 
Interestingly, chelation of extracellular Caβ+ did not prevent swelling-induced Caβ+ 
transients (Fig. βD and βG); this effect was similar to the lack of effect of 
extracellular Caβ+ removal on ICl,swell.  
As reported (47, 57), LRRC8A is an obligatory contributor of VRAC. To confirm its 
role in ICl,swell, we deleted LRRC8A (LRRC8A-/-) in HEKβ9γ cells using 
CRISPR/Cas9 approach. As expected, ICl,swell in LRRC8A-/- HEKβ9γ cells was 
dramatically reduced (Fig. γA, top panel). Exogenous over-expression of LRRC8A 
into LRRC8A-/- HEKβ9γ cells rescued the ICl,swell (Fig. γA, bottom panel and γC). 
These results confirm that LRCC8A-mediated VRAC is a major component of ICl,swell 
in HEKβ9γ cells. We also tested the effects of EGTA, BAPTA and thapsigargin on the 
exogenously expressed LRRC8A currents. In LRRC8A-/- HEKβ9γ cells re-transfected 
with LRRC8A, β0 mM EGTA in the pipette solution reduced the ICl,swell currents, and 
β0 mM BAPTA almost abolished the ICl,swell currents (Fig. γB and γD). Thus the 
ICl,swell produced by exogenously expressed LRRC8A is more sensitive to the Caβ+ 
chelators. Nonetheless, even in this case BAPTA and thapsigargin were significantly 
more potent than EGTA in inhibiting the ICl,swell currents (Fig. γB and γD).  
We then tested if ICl,swell could be directly activated by elevated intracellular Caβ+. 
Dialysis of ‘high-Caβ+’ pipette solution (free [Caβ+]i = 447 nM) under isotonic 
conditions was unable to activate ICl,swell-like currents either in the WT HEKβ9γ cells 
or in LRRC8A-/- HEKβ9γ cells transfected with LRRC8A (Fig. 4Aˈ4B, and 4D). To 
confirm that the dialysis of Caβ+ through the pipette in our experimental settings is 
effective, we used ANO1 as a Caβ+ sensor. In accord with our previous findings (γ0), 
the Caβ+-activated-chloride currents (CaCC) through ANO1 were activated when the 
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WT HEKβ9γ cells transfected with ANO1 were recorded with an isotonic pipette 
solution containing high-Caβ+ solution (447 nM; Fig. 4C).  
Taking together, the results presented in this section indicate that the Caβ+ released 
from the intracellular Caβ+ stores is an essential component in activation of 
LRRC8A-dependent ICl,swell; the Caβ+ signals necessary for the LRRC8A-dependent 
ICl,swell activation are local in nature, whereas ‘global’ cytosolic Caβ+ elevation does 
not activate the ICl,swell/LRRC8A directly.  
CaCC/ANO1 channels are also activated by the osmotic cell swelling. 
Thus far we have established that Caβ+ is necessary for the activation of 
LRCC8A-dependent ICl,swell. On the other hand, the CaCC/ANO1 channels were also 
implicated in the ICl,swell (5, 6). Thus, we next tested the contribution of CaCC/ANO1 
to the ICl,swell activation under our experimental conditions. It was reported that 
HEKβ9γ cells express low levels of endogenous ANO1 (4), thus, in order to 
rigorously test if ANO1 contributes to ICl,swell in HEKβ9γ cells, we first established a 
HEKβ9γ cell line with deletion of ANO1 (ANO1-/-) using CRISPR/Cas9 approach. 
The ICl,swell induced by the hypertonic pipette solution in ANO1-/- HEKβ9γ cells was 
significantly reduced (Fig. 5A and 5D). When ANO1 was overexpressed in WT 
HEKβ9γ cells (HEKβ9γ-ANO1), the ICl,swell was significantly increased as compared 
to that in WT HEKβ9γ cells (Fig. 5B and 5D). We also overexpressed ANO1 in 
LRRC8A-/- HEKβ9γ cells (LRRC8A-/- + ANO1). In this case, in the absence of 
LRRC8A, cell swelling induced by the hypertonic pipette solution activated a large 
outwardly rectifying current (Fig. 5C and 5E).  
Of note, altering levels of LRRC8A and ANO1 expression in HEKβ9γ cells 
significantly affected swelling-induced ICl,swell kinetics (Fig. 5A and 5B, right panels 
and Table 1). In the absence of ANO1 (ANO1-/- HEKβ9γ cells, Fig. 5A), ICl,swell 
displayed fast activation and prominent inactivation at more positive potentials; the 
inactivation was much more pronounces than that when the ANO1 was present (cf. 
Fig. 1A, bottom panel and 5A, right panel; see also Table 1). We assume that under 
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these conditions ICl,swell is mainly conducted by LRRC8 channels. In the absence of 
LRRC8A (LRRC8A-/- + ANO1, Fig. 5C) on the other hand, ICl,swell showed much 
slower activation and no inactivation. Under these conditions the ICl,swell is likely to be 
mostly conducted by ANO1. Cells in which both LRCC8A and ANO1 were present at 
the endogenous levels show ICl,swell with intermediate kinetics (Fig. 1A and Table 1); 
higher levels of LRCC8A resulted in increased inactivation (Fig. γA, bottom panel 
and Table 1) while higher levels of ANO1 resulted in appearance of slowly activating 
component and disappearance of inactivation (Fig. 5C and Table 1). Contribution of 
ANO1 to ICl,swell was also further confirmed when ICl,swell was activated by a 
extracellular hypotonic solution in LRRC8A-/- HEKβ9γ cells transfected with ANO1 
(data not shown). 
Adding further evidence that both LRRC8A and ANO1 contribute to ICl,swell, a Cl- 
current in HEKβ9γ was induced by GTP-S intracellularly applied under an isotonic 
condition (Fig. 5F-5H). Activation by GTP-S is a hallmark of ICl,swell (γ8). Again, as 
in the case of the swelling-activated current, the GTP-S-induced current in WT 
HEKβ9γ cells displayed inactivation at strong depolarization (Fig. 5F) but when 
LRCC8A was deleted and ANO1 overexpressed, the GTP-S-induced current became 
slowly-activating and lost its inactivation (Fig. 5G). 
Taking together, the results shown in Fig. 1, γ and 5 clearly demonstrate that 
endogenous LRRC8A and ANO1 proteins both contribute to the ICl,swell, although 
LRCC8A is being the dominant component. Exogenously expressed ANO1 as well as 
LRRC8A could also be activated by cell swelling. 
In light of our findings that intracellular Caβ+ is an essential but not a sufficient factor 
in activation of ICl,swell during the cell swelling, and that intracellular Caβ+ is sufficient 
to directly activate ANO1, which, in turn, can also be activated by cell swelling, we 
hypothesized that ANO1 could act as the Caβ+ sensor for LRRC8A activation. In 
support to this hypothesis is the fact that LRRC8A and ANO1 were reported to 
interact directly (5). Thus, we tested the Caβ+ dependency of ICl,swell activation in the 
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absence of ANO1. Similar to the activation of ICl,swell in the presence of both LRRC8A 
and ANO1 (WT HEKβ9γ cells), activation of ICl,swell in the absence of ANO1 (ANO1-/- 
cells) was still inhibited by BAPTA but not by EGTA added to the hypertonic pipette 
solution (Fig. 6A, 6B and 6E). This result indicates that the dependence of the ICl,swell 
activation from local Caβ+ does not require ANO1. We also tested if deletion of either 
LRRC8A or ANO1 would affect the swelling-induced rises in intracellular Caβ+, 
which was not the case (Fig. 6C, 6D and 6F). Likewise, chelation of extracellular Caβ+ 
did not prevent swelling-induced Caβ+ transients (Fig. 6C, 6D and 6F). 
Pharmacological characterization of ICl,swell 
The results presented above suggested that both LRRC8A and ANO1 could be 
activated by the cell swelling but these channels generate currents with different 
kinetics. We next studied if these two types of chloride currents have different 
sensitivity to pharmacological modulators of chloride channels and thus could be 
isolated pharmacologically. For this, we compared effects of two drugs: niflumic acid 
(NFA) and 4-(β-Butyl-6,7-dichlor-β-cyclopentyl-indan-1-on-5-yl) oxybutyric acid 
(DCPIB). NFA is a broad spectrum chloride channel inhibitor and our previous study 
shows that NFA has higher selectivity towards ANO1 as compared to another CaCC, 
Bestrophin 1 (γ0). DCPIB has been reported as a selective VRAC blocker (11, 16), 
but its effect on ANO1 has not been systematically tested. These two drugs were 
tested for their effects on three different current types: i) ICl,swell from WT HEKβ9γ 
cells (ICl,swell) induced with 4β0 mOsm pipette solution; ii) ICl,swell from ANO1-stably 
expressed HEKβ9γ cells (ICl,swell +ANO1) induced with 4β0 mOsm pipette solution; 
and iii) CaCC current from ANO1-stably expressed HEKβ9γ cells (CaCC/ANO1) 
induced with the isotonic pipette solution supplemented with 447 nM free Caβ+. 
Examples of whole-cell current traces recorded in these three different conditions and 
the effects of two drugs are shown in Fig. 7. The concentration dependencies for both 
compounds are analyzed in Fig. 7C and 7D, and summarized in Table β. NFA 
inhibited three types of current (measured at +100 mV) with potency (IC50) order of: 
CaCC/ANO1 (γ.γ5 ± 1.87 たM) > ICl,swell +ANO1 (95.8 ± 15.6 たM) > ICl,swell (471.4 ± 
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1γβ.8 たM). On the contrary, the sensitivity of the three currents to DCPIB had an 
inverted sequence: ICl,swel (5.69 ± 1.60 たM) ~ ICl,swell +ANO1 (7.04 ± β.β9 たM) > 
CaCC/ANO1 (18.8 ± β.71 たM). We also tested the sensitivity of the three types of 
currents to NFA and DCPIB at -60 mV and obtained the same orders of sensitivity as 
at +100 mV (Table β).  
NFA-sensitive component of ICl,swell +ANO1 gave rise to a very characteristic, slowly 
activating and non-inactivation current similar to these of ANO1-mediated CaCC (cf. 
Fig. 7B, top and 5C). On the contrary, the DCPIB-sensitive component of ICl,swel 
+ANO1 gave rise to the current with fast activation and inactivation, characteristic for 
the LRRC8A-mediated ICl,swell (cf. Fig. 7B, bottom and 5A). Collectively, these results 
clearly indicate that in HEKβ9γ cells swelling-activated ICl,swell +ANO1 has at least 
two components, mediated by LRRC8A and ANO1; these components have distinct 
kinetics and pharmacology. 
Probing cell signaling mechanisms for Ca2+ involvement in the activation of 
ICl,swell  
Since cell swelling-induced Caβ+ transients did not require extracellular Caβ+, we 
concluded that in this case Caβ+ is being released from the intracellular stores. One 
common signaling pathway for such intracellular Caβ+ transients is through 
phospholipase (PLC) mediated Caβ+ release from the endoplasmic reticulum Caβ+ 
stores. Thus, we first tested the role of PLC in the activation of ICl,swell, as was 
suggested in previous studies (9, 1γ, 60). PLC inhibitor U7γ1ββ (5 M) almost 
completely blocked the activation of ICl,swell (Fig. 8A, top and 8B), an effect that was 
not observed with the inactive analogue, U7γγ4γ (5 M) (Fig. 8A, bottom and 8B). 
We then synthesized a series of siRNAs against the PLC isoforms which are known to 
be highly expressed in HEKβ9γ cells (“THE HUMAN PROTEIN ATLAS” database): 
PLC1, PLC& , PLC and PLC. These siRNAs were individually transfected into 
the HEKβ9γ cells and their efficiency in inhibiting the activation of ICl,swell was tested. 
Among five PLC isoforms tested, knockdown of PLC1, PLC3 or PLC3 reduced the 
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activated ICl,swell significantly, whereas the knockdown of PLC4 and PLC1 had no 
effect (Fig. 8D). Taking together, these results indicate PLC isoforms were indeed 
involved in activation of ICl,swell. 
PLC hydrolyzes the plasma membrane phospholipid, phosphatidylinositol 
4,5-bisphosphate (PIPβ) into inositol 1,4,5-trisphosphate (IPγ) and 1,β-diacylglycerol 
(DAG), which in turn, results in the mobilization of intracellular Caβ+ and the 
activation of protein kinase C (PKC), respectively. We, thus, tested if the substrate of 
PLC, PIPβ is involved in the activation of ICl,swell. In the first series of experiments, we 
transfected HEKβ9γ cells with PLCh-PH-GFP, a fluorescent probe containing the 
PIPβ-binding domain from PLCh fused to GFP. This probe binds to PIPβ (51) and IPγ 
(for which the probe has higher affinity (19, β9, 56)). Using PLCh-PH-GFP as an 
optical probe for PIPβ hydrolysis, we could not detect a clear depletion of membrane 
of PIPβ under a condition of cell swelling (Data not shown).  
We next examined the effect of G-protein blocker GDP-s (500 M) and PKC 
inhibitor bisindolylmaleimide (BIM 200 nM) on the ICl,swell activation; no obvious 
effects of either of these compounds on the activation of ICl,swell were observed (Data 
not shown). Taken together these data suggest that while the Caβ+ required for the 
ICl,swell activation is likely to be produced by the PLC activity, this activity is perhaps 
independent of the GPCR activation; indeed PLCand isoforms are activated by 
Caβ+ and tyrosine kinases, respectively (17). In addition, this PLC activity is perhaps 
also highly localized as no global PIPβ depletion was observed.  
 
Discussion 
In this study we investigated molecular correlates and activation mechanisms of 
ICl,swell. We report the following findings: i) LRRC8A and ANO1 can both be 
activated by cell swelling. ii)  Both channels contribute biophysically and 
pharmacologically distinct components to the swelling-induced chloride currents in 
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HEK293 cells, with LRRC8A being the major component. iii) Both ICl,swell 
components require localized rather than global Ca2+ for activation. iv) While 
intracellular Ca2+ is necessary and sufficient to activate ANO1, it is necessary but not 
sufficient to activate LRRC8A-mediated currents. v) Ca2+ signals that are necessary 
for ICl,swell activation are mediated by the GPCR-independent PLC activation.  
The molecular identity of currents constituting ICl,swell, including VRAC, remained 
controversial until β014 when LRRC8A and its family members (LRRC8B-E) were 
shown to function as VRAC (47, 57). However, the other candidates such as ANO1, 
ANO6 and bestrophin1 were also proposed to contribute to ICl,swell in certain 
conditions (4, 6, 15, 34). Our results show that in LRRC8A knockout HEKβ9γ 
(LRRC8A-/-) cells, ICl,swell was almost abolished. When LRRC8A was transfected into 
LRRC8A-/- cells, ICl,swell was rescued but with somewhat altered properties (no 
oscillations, reduced requirements for local Caβ+; see below), suggesting that 
exogenously expressed LRRC8A can recapitulate most but not all the properties of 
endogenous ICl,swell. The reason for such partial phenotype could be, for example, in 
different membrane localization of exogenous and endogenous LRRC8A.  
In addition, our data clearly show that ANO1 can also generate ICl,swell, albeit, again, 
with some features which are clearly distinct from the endogenous ICl,swell (slow 
activation, no inactivation, stronger dependence on Ca2+). Specifically, ICl,swell was 
significantly reduced in ANO1-/-cells; in addition, ICl,swell was significantly increased 
in ANO1 overexpressed HEKβ9γ cells, and even in LRRC8A-/- cells transfected with 
ANO1. Interestingly, it was reported that ICl,swell was strongly suppressed in HEKβ9γ 
cells when LRRC8A was overexpressed and partially rescued in LRRC8A-/- cells 
re-transfected with LRRC8A (57). These authors hypothesized that LRRC8A is a part 
of a heteromeric VRAC and that LRRC8A overexpression leads to a subunit 
stoichiometry that is incompatible with normal channel activity. Here, we 
hypothesized ANO1 might be another key element of the VRAC complex, indeed a 
direct interaction between ANO1 and LRRC8A has been proposed (5). But how 
exactly ANO1 contributes to the VRAC activity is still unknown. The fact that 
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biophysically distinct ANO1-like and LRRC8A-like current fractions can be 
pharmacologically isolated from the macroscopic ICl,swell speaks against the formation 
of bona fide LRRC8A:ANO1 heteromeric channels with a common pore. Most likely 
both channels maintain independent pores and gating mechanisms. Yet, there is a 
remarkable level of coordination between two channels as both are activated by 
swelling and GDPs and both require local Caβ+ signals. 
Previous data from us and others suggest that ANO1 is endogenously expressed in 
HEKβ9γ cells, although at much lower levels than LRRC8A (16, 57). Yet, WT 
HEKβ9γ displays no obvious CaCC currents in electrophysiological experiments (Fig. 
4A). One possibility to explain some of the observed results, including a lack of 
CaCC in WT HEKβ9γ cells, is to hypothesize that under basal conditions the ion 
channels contributing to ICl,swell reside at the plasma membrane locations that are 
poorly accessible from cytosol. One example of such membrane structures is 
junctions between the plasma membrane and endoplasmic reticulum (ER-PM 
junctions). Recent studies indeed suggested a presence of ANO1 at such junctions (5, 
10, βγ, β6); it could be further hypothesized that VRAC channel complexes are also 
located at these or similar junctional domains. We further hypothesize that within 
these locations VRACs (and CaCCs) are very poorly accessible to ‘global’ cytosolic 
Ca2+ (e.g. Ca2+ dialyzed through the patch pipette). Cell swelling may induce i) 
mechanical rearrangements within the ER-PM junctions that expose the channels to 
cytosol and/or ii) increase in compartmentalized Ca2+ at the junctions. These evens 
would expose ANO1 and LRRC8 channels to Ca2+ and, ultimately, result in the ICl,swell 
activation (5). 
Indeed, both LRRC8A- and ANO1-mediated ICl,swell components required local Ca2+ 
for activation as the swelling-induced current was strongly reduced by BAPTA but not 
EGTA in WT HEKβ9γ cells. Pretreatment of the cells with thapsigargin (ER store 
depletion) also strongly suppressed ICl,swell. Interestingly, when either LRRC8A or 
ANO1 were overexpressed, they become more sensitive to global Caβ+: the current 
mediated by overexpressed LRRC8A became more sensitive to EGTA (Fig. γB and 
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γD) while overexpressed (but not endogenous) ANO1 could be activated by dialysis 
of Caβ+ through the patch pipette (Fig. 4C). These data indirectly support the 
hypothesis that endogenous Cl- channels contributing to ICl,swell are protected from 
global cytosolic Caβ+ and could only be activated by localized release of Caβ+ from 
the ER (e.g. upon cell swelling) while the overexpressed channels are much more 
open to global Caβ+ signals. 
It has to be pointed out that the contribution of intracellular Caβ+ signaling to VRAC 
activation has been debated (β, ββ). Many studies have demonstrated noticeable 
swelling-induced current even in the presence of high concentrations of Caβ+ chelators 
loaded into the cells or in the absence of observable [Caβ+]i rises in some cell types (β, 
β0, 40). These studies however could not rule out the requirements for highly 
localized Caβ+ signals reported here. Some reports have suggested the requirement of 
minimal basal [Caβ+]i (54). Akita and colleagues suggested that in cultured astrocytes, 
the swelling-induced activation of VRAC requires both, Caβ+-dependent and 
Caβ+-independent events. In line with this, a recent study showed that swelling 
induced taurine and glucose release mediated by VRAC exhibits both Caβ+-dependent 
and -independent mechanisms, which was related to the different VRAC heteromers 
expressed in human retinal cell lines (MIO-M1) (γ7). Thus, while conflicting 
evidence exist, Caβ+ does seem to play an important role for at least some steps in 
VRAC activation. 
How cell swelling is coupled to Caβ+ release from the ER is not entirely clear but our 
results show that in HEKβ9γ cells both the swelling-induced Caβ+ transients and the 
ICl,swell activation require the PLC; this observation is supported by several earlier 
reports (9, 1γ, 60). We show that PLC inhibition (U7γ1ββ) or down regulation 
(siRNA), or ER Caβ+ store depletion (thapsigargin), all significantly reduced or 
abolished ICl,swell. Yet, the GDP-S was unable to prevent swelling-induced ICl,swell 
activation and no obvious swelling-induced PIPβ depletion could be observed (Data 
not shown). Thus, exact mechanism by which swelling activates PLC and ER Caβ+ 
release remains to be solved; perhaps it relies mostly on the GPCR-independent PLC 
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isoforms, including PLC1 and PLC3. 
In the study, oscillation of ICl,swell amplitude was always seen when the cells swell. 
When the hypertonic intracellular solution was dialyzed into HEKβ9γ cells, or when 
cells were placed into the hypotonic extracellular solution, the cells began to swell 
and the ICl,swell started to develop. After reaching a maximum within several minutes, 
slow oscillations began; the first peak current was usually the largest. In some 
recordings these slow oscillations were observed for over an hour. Interestingly, the 
[Caβ+]i also displayed prominent oscillations, but this process had a significantly 
higher frequency: the times between first two peaks of ICl,swell and [Caβ+]i were 
calculated to be 9.7 and 4.7 min, respectively. If Caβ+ is required for ICl,swell activation, 
why the current and [Caβ+]i oscillations would not have the same kinetics? One 
potential explanation could be in that the kinetics of changes of local Caβ+ 
concentration in the immediate proximity of volume-sensitive Cl- channel and the 
kinetics of global cytosolic [Caβ+]i measured with fluo-4 may not be the same. Indeed, 
as we hypothesized above, VRACs may reside in the areas that are, to a degree, 
restricted from the rest of the cytosol; hindered diffusion of Caβ+ into these locations 
may, therefore, slowdown Caβ+ dynamics, which, in turn, results in slower current 
oscillations. We also measured the intracellular Caβ+ transients coupled with ICl,swell 
measurement in patch clamped cells. In this case, [Caβ+]i oscillations were also 
observed and again no time-matched kinetics of [Caβ+]i and ICl,swell were strictly 
correlated (data not shown). Thus the Caβ+ kinetics companying ICl,swell is a complex 
issue which need to be studied in further investigations. 
It is worthy to note that no oscillation of ICl,swell was reported before. We have some 
preliminary thoughts on why we are different with others on seeing such high proportion 
of ICl,swell oscillation. 1) The oscillation usually takes a slow start with an even slower 
oscillation cycle (e.g. Fig 1 and Fig β). In the literature, VRAC was usually recorded 
within 15 min (5, 47, 57), whereas we recorded VRAC in a much longer period of time; 
in another word, the oscillation of VRAC was simply being missed in others’ recordings. 
β) It seems that the oscillation of VRAC was most often seen in ICl,swell induced by the 
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hypertonic pipette solution than ICl,swell induced by the hypotonic external solution which 
in most cases was used in others’ experiments; in our case, 85% of 90 HEKβ9γ cells 
recorded using the hypertonic pipette solution developed multiple oscillation, whereas 
only γγ% of β7 HEKβ9γ cells recorded using the hypotonic external solution developed 
oscillation with more than β cycles. It is of note that the frequencies encoded in Caβ+ 
oscillations are reported to regulate many cellular processes such as exocytosis (γβ), 
apoptosis (4γ), fertilization (7) and cell growth (14); now VRAC can also be added to 
this list. The phenomenon of ICl,swell oscillation and its relationships with the 
swelling-induced oscillations of [Caβ+]i is fascinating and requires further 
investigation. 
In sum, here we show that both LRRC8A and ANO1 contribute to ICl,swell in HEKβ9γ 
cells and that ICl,swell activation requires localized, PLC-mediated Caβ+ release from 
the ER. The exact nature of ANO1-LRRC8A interactions during the ICl,swell activation 
is still unknown; the fact that activation of ICl,swell in the absence of ANO1 (ANO1-/- 
cells) still required local Caβ+ (Fig. 5) indicates that ANO1 is unlikely to just simply 
play a role of a Caβ+ sensor for LRRC8A. Clearly, future research is needed to 
decipher exact relationships between cell swelling, PLC, intracellular Caβ+ transients, 
LRRC8A, ANO1, VRAC and ICl,swell activation. 
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Table 1 Characteristics of activation and inactivation of ICl,swell in HEK293 cells 
with different level of ANO1 and LRRC8A expression. 
 
 I/SS Activation Inactivation 
(+100 mV) 1 (ms) 2 (ms) 1 (ms) 2 (ms) 
WT  β.90 ± 0.β6 N/A N/A γ7.6β ± 5.86 506.7 ± 67.β 
 ANO1-/- 4.β9 ± 0.4γ## N/A N/A γ8.78 ± 7.6β β90.9 ± 1γ.4** 
 LRRC8A-/- + ANO1 0.γ4 ± 0.0β## 50.0β ± 9.1β β8γ.8 ± 6β.4 N/A N/A 
LRRC8A-/- + LRRC8A 1.5β ± 0.09## N/A N/A 606.6± 99.1() 
I/SS, the ratio of instantaneous and pseudo steady state current amplitudes measured 
at +100 mV. All values are means ± S.E.M (n = 6-11). N/A, not available 
**P < 0.01, ##P < 0.01, compared with current recorded in WT HEKβ9γ cells. 
 
Table 2 Inhibition effects of NFA and DCPIB on ICl,swell and CaCC currents 









 -60 mV +100 mV -60 mV +100 mV 
CaCC/ANO1 N/A γ.γ5 ± 1.87 β7.7 ± γ.96 18.8 ± β.71 
ICl,swell 740.β ± 78.4 471.4 ± 1γβ.8 6.γ4 ± 1.45 5.69 ± 1.6 
ICl,swell +ANO1 ββ0.4 ± 44.1 95.8 ± 15.6 7.75 ± 1.56 7.04 ± β.β9 
All values are means ± S.E.M (n = 4-16). N/A, no activity. 
ICl,swell were induced by the hypertonic intracellular solution in HEKβ9γ cells (ICl,swell), 
or in HEKβ9γ cells over-expressing ANO1 (ICl,swell +ANO1); CaCC currents were 
induced by isotonic intracellular solution containing high Caβ+ (447 nM) in CHO cells 





Fig. 1. Local Ca2+ plays an essential role in activation of VRACs.  
The cells were continuously held at -60 mV and stimulated with 1 s voltage ramps 
from -100 mV to +100 mV applied with 60s interval; to measure current-voltage 
relationships voltage steps from -100 mV to +100 mV in β0 mV increments were 
applied instead of the ramps. The dotted lines indicate the zero current level. A: top, 
volume regulated chloride current (ICl,swell) recorded in HEKβ9γ cell elicited by 4β0 
mOsm hypertonic pipette solution. Bottom, the representative current traces induced 
by ramp (left) and step (right) voltage protocols, respectively. In the top panel, the 
times at which ramp- and step-induced I/V relationships were obtained are indicated 
by numbers (1, β) and asterisk, respectively. DCPIB (10 M) was applied at the end 
of the recording during the time indicated by grey shading. B: top and middle, 
representative current traces of ICl,swell induced by the hypertonic pipette solution with 
β0 mM EGTA or β0 mM BAPTA, as indicated. Bottom, representative current traces 
of ICl,swell induced by the hypertonic pipette solution in HEKβ9γ cells treated with β 
たM thapsigargin; thapsigargin was applied 15 min before and was perfused 
continuously during the experiment. C: summary data for maximal current densities 
of ICl,swell (recorded at -60 mV) from experiments presented in panels (A and B). **P 
< 0.01, compared with the control HEKβ9γ cells. D and E: summary data for maximal 
current densities of ICl,swell (recorded at -60 mV) from ANO1 stably-transfected CHO 
cells and DRG neurons. **P < 0.01, compared with the control cells. 
  
Fig. 2. No effects of extracellular Ca2+ on ICl, swell or intracellular Ca2+ transients. 
The HEKβ9γ cells were continuously held at -60 mV and stimulated with 1 s voltage 
ramps from -100 mV to +100 mV applied with 60s interval; to measure 
current-voltage relationships voltage steps from -100 mV to +100 mV in β0 mV 
increments were applied instead of the ramps. The dotted lines indicate the zero 
current level. A: representative current traces of ICl,swell induced by ββ0 mOsm 
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hypotonic bath solution in the absence or presence of EGTA. B: representative current 
traces of ICl,swell induced by the hypotonic bath solution with β0 mM EGTA or β0 mM 
BAPTA in the γβ0 mOsm isotonic pipette solution, as indicated. C and D: 
intracellular Caβ+ transients recorded with Fluo-4-AM (β M). Time courses of Fluo-4 
fluorescence intensity from three HEKβ9γ cells indicated by the arrowheads in the 
insets on the left; insets depict cells before (a) and during (b) application of the 
hypotonic bath solution (ββ0 mOsm) in the absence (C) or presence (D) of EGTA. E 
and F: summary data for maximal current densities of ICl,swell (recorded at -60 mV) 
from experiments presented in panels (A and B). ***P < 0.001, compared with the 
control HEKβ9γ cells. G: summary for the maximal change in Fluo-4 fluorescence 
intensity (normalized to the initial fluorescence intensity, F0) during the first transient 
induced by hypotonic bath solution in the absence or presence of EGTA (from the 
experiments as these shown in the panels (C and D), respectively. In (E-G), number of 
recordings in more than γ sets of experiments is indicated within each bar. 
 
Fig. 3. Local Ca2+ is essential for activation of LRRC8A currents.  
A: overexpression of LRRC8A in HEKβ9γ cells lacking endogenous LRRC8A 
(LRRC8A-/-) rescued ICl,swell elicited by 4β0 mOsm hypertonic pipette solution. B: 
BAPTA and thapsigargin (Thap) were more efficient than EGTA in preventing 
activation of LRRC8A currents. In (A and B) the recording conditions are similar to 
the experiments shown in Figure 1. Where indicated by grey shading, 10 M DCPIB 
was applied at the end of the recording. C: summary data for experiments exemplified 
in (A), maximal current densities were measured at -60 mV. **P < 0.01, compared 
with current recorded in WT HEKβ9γ cells. D: summary data for experiments 
exemplified in (B), maximal current densities were measured at -60 mV. ***P < 0.001, 
compared with the control LRRC8A-/- cells transfected with LRRC8A. In (C and D), 
number of recordings in more than γ sets of experiments is indicated within each bar. 
 




A-C: WT HEKβ9γ cells (A), LRRC8A-/- HEKβ9γ cells transfected with LRRC8A (B) 
and HEKβ9γ cells transfected with ANO1 (C), were perfused with a pipette solution 
contained 447 nM free Caβ+ and the whole-cell currents were recorded using the ramp 
voltage protocol shown at the top right inset in (A). The osmolality of the pipette 
solution was an isotonic (γβ0 mOsm). D: summarized maximal current densities 
measured at -60 mV and +100 mV from the experiments exemplified in panels (A-C). 
**P < 0.01, ##P< 0.01 compared with WT HEKβ9γ; number of recordings in more 
than γ sets of experiments is indicated under the bars. 
 
Fig. 5. ANO1 is activated by cell swelling and contributes to VRAC.  
A-C: left, ICl,swell recorded in HEKβ9γ lacking ANO1 (HEKβ9γ ANO1-/-), HEKβ9γ 
transfected with ANO1 (HEKβ9γ-ANO1) and HEKβ9γ LRRC8A-/- transfected with 
ANO1; ICl,swell was elicited with 4β0 mOsm hypertonic pipette solution and recorded 
as in Figure 1. Right, the representative current traces induced by step protocol (top 
inset) at the times indicated by asterisks. D: summary data for experiments 
exemplified in (A), maximal current densities were measured at -60 mV, **P < 0.01, 
***P < 0.001 compared with the current recorded in HEKβ9γ cells. E: summary data 
for experiments exemplified in (C), maximal current densities were measured at -60 
mV and +100 mV. **P < 0.01, ##P< 0.01 compared with the current recorded in 
LRRC8A-/- cells at -60 mV and +100 mV, respectively. F and G: representative current 
traces recorded from HEKβ9γ cells (F) and LRRC8A-/- HEKβ9γ cells transfected with 
ANO1 (G). Currents were elicited by the dialysis of isotonic (γβ0 mOsm) pipette 
solution containing β00 たM GTP-けs. DCPIB (10 M) was applied at the end of the 
recording during the time indicated by grey shading. H: Summary data for current 
densities of ICl,swell from experiments presented in panel (F and G). **P < 0.01 





Fig. 6. Genetic deletion of either ANO1 or LRRC8A did not affect the ICl,swell and 
intracellular Ca2+ transits induced by a hypotonic extracellular solution. 
A and B: BAPTA but not EGTA prevented activation of ICl,swell in HEKβ9γ cells 
lacking ANO1. In some experiments, 10 M DCPIB was applied at the end of the 
recording during the time indicated by grey shading. C and D: genetic deletion of 
either ANO1 or LRRC8A did not affect the intracellular Caβ+ transits induced by a 
hypotonic extracellular solution. E: summary data for current densities of ICl,swell from 
experiments presented in panel (A and B). ***P < 0.001 compared with ANO1 
lacking HEKβ9γ cells at -60 mV. F: summary for the maximal change in normalized 
Fluo-4 fluorescence intensity during the first transient induced by hypotonic bath 
solution in experiments as those shown in (C and D).  
 
Fig. 7. Effects of Cl- channel inhibitors on ICl,swell and CaCC currents.  
A: representative current traces induced by voltage ramps from -100 to +100 mV 
(from a holding potential of -60 mV) during the application of different 
concentrations (as indicated) of NFA and DCPIB. ICl,swell was induced with 4β0 mOsm 
hypertonic intracellular solution in WT HEKβ9γ cells; ICl,swell +ANO1 was induced 
with 4β0 mOsm hypertonic intracellular solution in HEKβ9γ cells stably transfected 
with ANO1 (HEKβ9γ-ANO1); and CaCC/ANO1 was induced with high free Caβ+ 
(447 nM) isotonic intracellular solution in HEKβ9γ-ANO1 cells. B: NFA and DCPIB 
selectively inhibited different components of ICl,swell in HEKβ9γ-ANO1 cells. Currents 
were recorded using step voltage protocol (Figure. 1(A)). NFA and DCPIB sensitive 
current fractions were obtained by subtracting residual currents in the presence of a 
drug from the total ICl,swell before drug application. C and D: NFA and DCPIB 
concentration-response relationships for three different currents recorded at +100 mV. 
The data were fitted with a logistic function; the IC50 values are shown.  
 
Fig. 8. PLC isoforms are required for the ICl,swell activation.  
A: ICl,swell elicited by the hypertonic pipette solution containing β0 mM EGTA was 
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blocked by the PLC blocker, U7γ1ββ (5 たM; upper trace) but not by the inactive 
analogue, U7γγ4γ (5 たM; lower trace). HEKβ9γ cells were pre-treated with either of 
the drug for β0 min; the drugs were also present in extracellular solution during the 
recording. CaCCinh-A01 (100 M) was applied at the end of the recording during the 
time indicated by grey shading. B: summary data for experiments exemplified in the 
panel (A). **P < 0.01, compared with the control HEKβ9γ cells. C: efficiency of 
PLC-siRNAs knockdown (as indicated) on HEKβ9γ cells. The scrambled siRNA 
control and siRNA against PLC isoforms were transfected into HEKβ9γ cells 7β h 
before tested using Real time PCR approach. D: summary data for effect of siRNA 
against different PLC isoforms on ICl,swell recorded at the holding potentials of -60 mV. 
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